DD209833A5 - Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen - Google Patents
Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen Download PDFInfo
- Publication number
- DD209833A5 DD209833A5 DD83250187A DD25018783A DD209833A5 DD 209833 A5 DD209833 A5 DD 209833A5 DD 83250187 A DD83250187 A DD 83250187A DD 25018783 A DD25018783 A DD 25018783A DD 209833 A5 DD209833 A5 DD 209833A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- general formula
- spiro
- hydrogen atom
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD209833A5 true DD209833A5 (de) | 1984-05-23 |
Family
ID=9273425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD83250187A DD209833A5 (de) | 1982-04-27 | 1983-04-25 | Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS5910584A (es) |
| KR (1) | KR840004428A (es) |
| AT (1) | ATA125383A (es) |
| AU (1) | AU1395383A (es) |
| BE (1) | BE896572A (es) |
| DD (1) | DD209833A5 (es) |
| DE (1) | DE3315106A1 (es) |
| DK (1) | DK183583A (es) |
| ES (1) | ES8405796A1 (es) |
| FR (1) | FR2525603A1 (es) |
| GB (1) | GB2133401B (es) |
| GR (1) | GR78481B (es) |
| IL (1) | IL68497A0 (es) |
| IT (1) | IT1167123B (es) |
| LU (1) | LU84770A1 (es) |
| MA (1) | MA19783A1 (es) |
| NL (1) | NL8301476A (es) |
| NO (1) | NO831473L (es) |
| OA (1) | OA07412A (es) |
| PT (1) | PT76595B (es) |
| SE (1) | SE8302347L (es) |
| ZA (1) | ZA832927B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| EP1636191A2 (en) | 2003-06-17 | 2006-03-22 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| CN1805938B (zh) | 2003-06-17 | 2010-06-16 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物 |
| NZ555981A (en) | 2004-12-21 | 2011-01-28 | Arena Pharm Inc | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| EP1833473B1 (en) | 2004-12-23 | 2009-09-09 | Arena Pharmaceuticals, Inc. | 5ht2c receptor modulator compositions and methods of use |
| CA2646044A1 (en) | 2006-04-03 | 2007-10-25 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto |
| CA2670285A1 (en) | 2006-12-05 | 2008-06-12 | Arena Pharmaceuticals, Inc. | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| WO2009111004A1 (en) | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
| CN102648170A (zh) | 2009-06-18 | 2012-08-22 | 艾尼纳制药公司 | 制备5-ht2c受体激动剂的方法 |
| US9045431B2 (en) | 2010-06-02 | 2015-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| MX2013002418A (es) | 2010-09-01 | 2013-08-01 | Arena Pharm Inc | Administracion de lorcaserina a individuos con daño renal. |
| SG188361A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Non-hygroscopic salts of 5-ht2c agonists |
| CN103189053A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 用于体重控制的5-ht2c激动剂的调节释放剂型 |
| JP2013539470A (ja) | 2010-09-01 | 2013-10-24 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ロルカセリンと光学活性な酸との塩 |
| BR112015007779A2 (pt) | 2012-10-09 | 2017-07-04 | Arena Pharm Inc | célula de fluxo de permeabilidade e sistema de condutância hidráulica |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Application Discontinuation
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 PT PT76595A patent/PT76595B/pt unknown
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-27 OA OA57984A patent/OA07412A/xx unknown
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 ES ES521895A patent/ES8405796A1/es not_active Expired
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2525603B1 (es) | 1984-09-14 |
| JPS5910584A (ja) | 1984-01-20 |
| PT76595B (fr) | 1986-01-21 |
| BE896572A (fr) | 1983-10-26 |
| MA19783A1 (fr) | 1983-12-31 |
| FR2525603A1 (fr) | 1983-10-28 |
| KR840004428A (ko) | 1984-10-15 |
| PT76595A (fr) | 1983-05-01 |
| SE8302347D0 (sv) | 1983-04-26 |
| IT8348155A0 (it) | 1983-04-26 |
| OA07412A (fr) | 1984-11-30 |
| IL68497A0 (en) | 1983-07-31 |
| SE8302347L (sv) | 1983-10-28 |
| GB8311508D0 (en) | 1983-06-02 |
| DK183583A (da) | 1983-10-28 |
| NO831473L (no) | 1983-10-28 |
| AU1395383A (en) | 1983-11-03 |
| NL8301476A (nl) | 1983-11-16 |
| IT1167123B (it) | 1987-05-13 |
| ATA125383A (de) | 1986-05-15 |
| GR78481B (es) | 1984-09-27 |
| GB2133401B (en) | 1985-10-23 |
| LU84770A1 (fr) | 1984-11-28 |
| DE3315106A1 (de) | 1983-11-03 |
| GB2133401A (en) | 1984-07-25 |
| ES521895A0 (es) | 1984-06-16 |
| ES8405796A1 (es) | 1984-06-16 |
| ZA832927B (en) | 1984-06-27 |
| DK183583D0 (da) | 1983-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD209833A5 (de) | Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen | |
| DE2933441C2 (de) | Spiro-[4H-2,3-dihydrobenzopyran(4,5')oxazolidin]-2',4'-dione und solche Verbindungen enthaltende Arzneimittel | |
| AT392790B (de) | Verfahren zur herstellung von neuen 2,3-dihydro-2-oxo-1h-imidazo-(4,5-b)-chinolinyletherderivaten und den pharmazeutisch vertraeglichen salzen davon | |
| DE69320734T2 (de) | 3-(Hydroxybenzylidenyl)-Indolin-2-one und diese enthaltende Arzneimittel | |
| EP0204349A2 (de) | Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| CH653684A5 (fr) | Derives de carbostyrile, procede pour leur preparation et compositions les contenant. | |
| US5250547A (en) | Benzopyran derivatives | |
| DE19604920A1 (de) | Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel | |
| EP0222693A2 (de) | Neue 3-Oxadiazol- und 3-Carbonsäure-beta-Carbolinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel | |
| DE69317399T2 (de) | Aminocycloalkanobenzodioxole als beta-3 selektive adrenergische Wirkstoffe | |
| US4775695A (en) | Substituted amidinoalkoxy and amidinoalkylamino indanones and salts thereof | |
| EP0255028A2 (de) | Neue 1,4-Benzodiazepine, ihre Herstellung und Verwendung als PAF Antagonisten | |
| EP0185909A1 (de) | 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| EP0072960B1 (de) | 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| EP0002672B1 (de) | Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| DE3721223C2 (es) | ||
| JP2684566B2 (ja) | ２０，２１―ジノルエブルナメニン誘導体の光学活性体の抗抑うつ剤としての使用及びそれらを含有する製薬組成物 | |
| EP0146787B1 (de) | Indolderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| DE69709869T2 (de) | BENZO[g]CHINOLIN DERIVATE | |
| US5262422A (en) | Octahydrobenzo[g]quinoline | |
| HU200603B (en) | Process for producing substituted quinoxalinyl-imidazolidin-2,4-diones and pharmaceutical compositions comprising such compounds | |
| US5240948A (en) | 3-(3-alkylthiopropyl)benzothiazoline derivatives, their preparation and the medicament containing them | |
| DD210266A5 (de) | Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten | |
| EP0364254A2 (en) | Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine derivatives and related compounds | |
| EP0289881A2 (de) | Neue 2-Aminoalkyl-4-bennzyl-1-(2H)-phthalazinon-Derivate |